A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity
Clinical trial NCT00712322 · TERMINATED
Trial details
- NCT number
- NCT00712322
- Sponsor
- Warner Chilcott
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-07
- Primary completion
- 2013-05-23
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.